CHMP calls for more research into possible links between vaccination and narcolepsy in young
This article was originally published in Scrip
Executive Summary
Having reviewed further data from Finland on the suspected link between narcolepsy in children and adolescents and GlaxoSmithKline's pandemic flu vaccine Pandemrix, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that while the new evidence raises additional concerns, the data are still insufficient to establish a causal relationship.